Hetero will produce and launch the first generic Remdesivir under Covifor brand in India following positive clinical outcomes under a licensing agreement with Gilead Sciences Inc to expand access to Covid-19 treatment in low and middle-income economies.from Industry-Economic Times
Read The Rest:economictimes...
